Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management

Browse trials for

• Hypertension 6,689

Keywords

• Epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication

Hypertension

6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.

This study's enrollment of 899 is above the median of 210 across 1,359 observational studies indexed under Hypertension.

Lead sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc. is the lead sponsor of 431 studies on the registry; none are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 8 (89%) have results posted.

Study population

Groups and cohorts

• Hypertensive Subjects undergoing primary prevention

  Other: Usual Care

Interventions

• OtherUsual Care

  Normal care for hypertensive patients with risk factors for CHD

Primary outcomes

1. Description of hypertensive patients in terms of presence of associated cardiovascular (CV) risk factors (number of additional CV risk factors and frequency)

Secondary outcomes

1. Description of pattern of management of HT and CVD prevention, through lifestyle and use of drug therapies,

2. Estimate adherence to treatment using the Morisky Adherence Scale (MAS)

3. Estimation of hypertensive patients CV risk stratification based on ESH/ESC Hypertension Guidelines 2007 and to compare it with physicians' estimation of CV risk.